Global Health Tech Insights
A health tech company in Egypt, Almoneer, has successfully raised $3.6 million to tackle diabetes and obesity, contrasting sharply with a struggling US startup facing downsizing. As the US grapples with the fallout from trendy weight loss drugs like Ozempic, Almoneer's approach could offer a fresh perspective on treatment strategies. The conversation highlights the differences in healthcare solutions across countries and the need for transparency regarding treatment outcomes.In this clip
From this podcast
Equity
'Buy now, pay later' is just another way of saying 'debt'
Related Questions